Explore more publications!

Niue Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Niue Health Report.

Press releases published on November 12, 2025

SELLAS Life Sciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London
Fractyl Health Reports Third Quarter 2025 Results; Revita® Clinical Momentum Builds Toward 2026 Pivotal Readout and PMA Filing, Cash Runway Extended into Early 2027
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2025 
Echo IQ Highlights Market Potential for EchoSolv AS Following Presentation of New Data for Severe Aortic Stenosis (AS) Presented at AHA Scientific Sessions 2025
Korro Reports Third Quarter Financial Results, Provides Updates on KRRO-110 in Alpha-1 Antitrypsin Deficiency and Additional Pipeline Programs
Kura Oncology to Participate in Upcoming Investor Conference
Immuneering Reports Third Quarter 2025 Financial Results and Provides Business and Clinical Updates
GE HealthCare and RadNet’s DeepHealth Division Sign Letter of Intent to Advance Innovation and Adoption of AI-Powered Imaging Across Multiple Modalities and Remote Scanning
Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress
Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
MaxCyte Reports Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance
Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update
BBOT Reports Third Quarter 2025 Financial Results and Update on Corporate Progress
Nusano Receives Innovation Impact Award from BioUtah
NurExone Secures over C$3.18 Million Through Accelerated Warrant Exercises
Mdxhealth Reports Results for the Third Quarter and  Nine-Month Period Ended September 30, 2025
Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in London
Erasca Reports Third Quarter 2025 Business Updates and Financial Results

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions